No abstract available.
Graves Disease*

No abstract available.
Graves Disease*

Graves' disease (GD) and Guillain-Barre syndrome (GBS) are both autoimmune disorders and are triggered by interactions between genetic and environmental factors. GBS in patients who suffer from other autoimmune diseases is rarely reported, and the development of atypical GBS with cranial nerve involvement in a patient with GD has never been previously reported. Herein, we report a patient with GD and a rare form of pharyngo-cervico-brachial variety of GBS.

No abstract available.
Genetics* ; Graves Disease*

No abstract available.
Graves Disease* ; Hypothyroidism*

No abstract available.
Diagnosis* ; Graves Disease* ; Korea*

After a 4 weeks of treatment by propyl thyouracil, the biochemical indices of Basedow disease had changed obviously: triiodothyronin (T3) high level (7.95 ± 1.58 nmol/l before treatment) had increased dramatically (1.98 ± 0.54 nmol/l), total thyroxin (T4) high level (257.56 ± 47.45 nmol/l before treatment) had decreased dramatically (1278.04 ± 10.82 nmol/l). FT4 serum level high level had decreased after treatment. TSF low level before treatment had increased. But after treatment glucose level had increased unsignificantly versus that before. In severe condition blood cholesterol had increased, but in moderate and mild condition, there was no change.
Blood ; Therapeutics ; Graves Disease

Studied on 360 patients Basedow in Endocrinology Centre of Hoa Binh province from 1/10/1998-1/10/2000. Results of the study were used by biological statistic with the software SPSS 10.0. Results showed that: Among all samples, 78.89% of patients were effectively treated. All the symptoms (except proptosis) and basic metabolic data were improved. ECG and thyroid ultrasound examination results were also significantly improved. However, the rate of compliance was relatively low. Only 26.11% of patients completed all 3 stages of the clinical trial
Graves Disease ; Therapeutics ; Endocrinology

175 Basedow’s disease patients (45 males and 170 females; mean age: 44.48 ± 8.89) were treated by I-131 at Bach Mai hospital and Military Hospital 103. Total T3 level in serum was 6.45 ± 2.81 nmol/l (n=146) and total T4 level was 243.58 ± 72.34 nmol/l (n=143). Before treatment T3 and T4 level increased abnormaly comparing with healthy people. By 4 months of treatment, T3 level was 2.15 ± 0.78 nmol/l and T4 level was 120.35 ± 36.81nmol/l, FT4 level was 15.67 ± 6.51pmol/l. With average dose of 6.52 ± 1.64 mCi I-131, most of patients had normalized total T3, T4 level
Graves Disease ; Therapeutics

For the past 60 years, there have been millions with hyperthyroidism and Basedow patients treated successfully by radioiodine (I-131). The number of patients with hyperthyroidism and Basedow treated by I-131 was the same as this received operations. The radioiodine therapy was a safe, effective and economic method with easy to implement that should be selected among methods of treatment of hyperthyroidism and Basedow
Hyperthyroidism ; Graves Disease ; Therapeutics